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Abstract
While isogenic DT40 cell lines deficient in DNA repair pathways are a great tool to understand the DNA damage response to
genotoxic agents by a comparison of cell toxicity in mutants and parental DT40 cells, no convenient mutation assay for
mutagens currently exists for this reverse-genetic system. Here we establish a proaerolysin (PA) selection-based mutation
assay in DT40 cells to identify glycosylphosphatidylinositol (GPI)-anchor deficient cells. Using PA, we detected an increase in
the number of PA-resistant DT40 cells exposed to MMS for 24 hours followed by a 5-day period of phenotype expression.
GPI anchor synthesis is catalyzed by a series of phosphatidylinositol glycan complementation groups (PIGs). The PIG-O gene
is on the sex chromosome (Chromosome Z) in chicken cells and is critical for GPI anchor synthesis at the intermediate step.
Among all the mutations detected in the sequence levels observed in DT40 cells exposed to MMS at 100 mM, we identified
that ,55% of the mutations are located at A:T sites with a high frequency of A to T transversion mutations. In contrast, we
observed no transition mutations out of 18 mutations. This novel assay for DT40 cells provides a valuable tool to investigate
the mode of action of mutations caused by reactive agents using a series of isogenic mutant DT40 cells.
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Introduction
Research on gene function and regulation is of paramount
importance for investigations into the causes of many diseases such
as cancer. One very effective approach investigators have been
using involves the reverse genetic technique making use of cell
lines like the DT40 line which is derived from a chicken B-
lymphocyte progenitor. DT40 cells were originated by making use
of an avian leucosis virus to induce a bursal lymphoma and the cell
line is considered to be isogenic [1]. The DT40 cell line has
distinguished itself as being highly valuable as a higher eukaryotic
model that exhibits a high ratio of targeted to random integration
of transfected DNA [2,3]. This ease of genetic manipulation, along
with the fact that DT40 mutants have been observed to display a
strong phenotypic resemblance to murine mutants in DNA
recombination and repair [4], has been the foundation that has
created a steadily increasing interest in the usage of the DT40 cell
line in genetic investigations into immunoglobulin diversification,
DNA repair, DNA damage response, chromosome segregation,
RNA metabolism and cell signaling [3–7].
One downside to the DT40 cell system, however, is that for the
last two decades there has been no convenient mutation assay to
investigate mechanisms of mutagenicity caused by exogenous
reactive agents. One approach to detect mutations in mammalian
cells is based on the endogenous gene, hypoxanthine-guanine
phosphoribosyltransferase (HPRT), located on the X chromosome
[8]. This method has been extensively utilized in toxicology [9,10].
The HPRT mutants from cultured cells and tissues of animals
exposed to mutagens are resistant to the toxic nucleoside 6-
thioguanine, which allows the selection of mutant cells. Thus,
mutation rates and mutational sequences in the HPRT locus can
be analyzed in 6-thioguanine-resistant cells. While the HPRT
mutation assay has gained popularity in mutational analysis in
mammalian cells, this assay is difficult to perform in DT40 cells
due to the presence of the HPRT gene on the autosomal
chromosome (chromosome 4) in chicken cells instead of the sex
chromosome.
Recently, a novel mutation assay was developed in rats, making
use of the endogenous phosphatidylinositol glycan complementa-
tion group A (Pig-a) gene for red blood cells and T-lymphocytes
[11,12]. The PIG-A gene has several characteristics that make it
well suited for the detection of somatic cell mutations. Although
over 20 PIG genes, including PIG-A, were identified for GPI
anchor synthesis (Figure 1), only the PIG-A gene is located on the
X chromosome in mammalian cells (Table 1) [13]. As with the
HPRT mutation, a single mutation on the PIG-A gene results in an
altered cell phenotype in mammalian cells. PIG-A codes for an
enzyme that, along with five other cores and one extra subunit
(PIG-C/-H/-P/-Q/-Y and DPM2), is involved in the first step of
GPI anchor synthesis (Figure 1) [13–17]. The functions of all six
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synthesis [17]. GPI anchors tether specific protein markers to the
surface of various types of cells (e.g., hematopoietic cells) [18,19].
Thus, mutations in the PIG-A gene could disrupt GPI anchor
synthesis which, in turn, would cause a deficiency in GPI-
anchored proteins. Lack of the anchor or GPI-anchored proteins
can be detected and quantified using a flow cytometer.
Furthermore, proaerolysin (PA) has been successfully utilized in
spleen T-cells to select for GPI anchor-deficient cells in the Pig-a
mutation clonal assay [20]. PA is a protoxin form of aerolysin,
which is a channel-forming microbial toxin [21–23]. After binding
to GPI at the cell surface, PA is proteolytically cleaved into
aerolysin, which ultimately forms transmembrane pores [24] and
causes cell death. Mutations in the PIG-A gene abrogate GPI
anchor synthesis and deplete GPI anchors at the surface of cells.
Therefore, the GPI anchor-deficient mutant cells become resistant
to aerolysin-induced cytotoxicity. In addition to determining the
frequency of PIG-A gene mutations, it is possible to determine the
PIG-A mutation spectrum through sequencing following RT-PCR
of mRNA extracted from cells resistant to PA [20]. However, the
PIG-A gene is also located on an autosome in DT40 cells (Table 1).
DT40 cells were established from B lymphocytes of female
chickens having female heterogamety with Z and W sex
chromosomes. Both PIG-G and PIG-O genes are involved in GPI
anchor synthesis; however, in contrast to the PIG-A gene, both are
located on chromosome Z. Modification of the GPI anchor by
PIG-G is not essential for the function of the GPI anchor at the
cellular level [25]. However, a complex of PIG-O and PIG-F
catalyzes an attachment of phosphoethanolamine to the third
mannose of the GPI anchor in the final step (Figure 1) immediately
before attachment of the GPI anchor and cell surface protein.
Since the phosphoethanolamine attached to the third mannose is
the location where the surface protein binds, the PIG-O gene
product is nearly essential for GPI anchor synthesis [26]. In the
present study, we established a new PIG-O gene mutation assay to
analyze the mutagenicity of reactive chemicals in DT40 cells
through PA selection.
Results and Discussion
Cytotoxicty of PA in DT40 cells
A concentration of PA suitable for the selection of GPI anchor-
deficient DT40 cells was established using intact DT40 cells. In a
low cell density experiment using a 24-well plate (2.5610
3 cells/
250 mL/well), the DT40 cells were exposed to PA at 0.125 nM or
lower for three days. PA caused marked cell death in DT40 cells at
0.125 nM (Figure 2A). Furthermore, in a high cell density
Figure 1. Biosynthesis of the glycosylphosphatidyl inositol
(GPI)-anchored protein. Synthesis of GPI-anchored proteins involves
multiple reaction steps. Briefly, the first step of GPI anchor biosynthesis
is catalyzed by a multi-subunit GPI-N-acetylglucosaminyltransferase
comprised of at least 6 different proteins (PIG-A, PIG-C, PIG-H, PIG-P,
PIG-Q, PIG-Y). In addition, DPM2 appears to regulate this first step,
followed by de-N-acetylation by the PIG-L. PIG-W then attaches an acyl
chain to form glucosamine-(acyl)PI. In the next step, three mannose
(Man) residues are added sequentially to glucosamine-(acyl)PI, gener-
ating Man-Man-Man-glucosamine-(acyl)PI by PIG-M/PIG-X complex, PIG-
V, and PIG-B. After the Man-1 and Man-2 conjugation, PIG-N adds
ethanolamine phosphates (EtNP) to the Man-1. In the final step of GPI
anchor synthesis, PIG-O/PIG-F and PIG-G/PIG-F complexes attach EtNP
to the Man-3 and Man-2, respectively, to generate the mature GPI
anchor protein.
doi:10.1371/journal.pone.0033563.g001
Table 1. Chromosome location of GPI anchor synthesis
genes.
chicken human rat
PIG-A Chr 1 Chr X Chr X
PIG-C Chr 8 Chr 1 Chr 13
PIG-P Chr 1 Chr 21 Chr 11
PIG-H Chr 5 Chr 14 Chr 6
DPM2 Chr 17 Chr 9 Chr 3
PIG-Y N.I. Chr 4 Chr 4
PIG-Q Chr 14 Chr 16 Chr 10
PIG-L Chr 19 Chr 17 Chr 10
PIG-W Chr 19 Chr 17 Chr 10
PIG-M Chr 3 Chr 1 Chr 13
PIG-X Chr 9 Chr 3 Chr 11
PIG-V N.I. Chr 1 Chr 5
PIG-N Chr 2 Chr 18 Chr 13
PIG-B N.I. Chr 15 Chr 18
PIG-F N.I. Chr 2 Chr 6
PIG-O Chr Z Chr 9 Chr 5
PIG-G Chr Z Chr 4 Chr 14
PIG-S Chr 19 Chr 17 Chr 10
PIG-T Chr 20 Chr 20 Chr 3
PIG-U Chr 20 Chr 20 Chr 3
PIG-K Chr 8 Chr 1 Chr 2
GAA1 N.I. Chr 8 Chr 7
Chr: Chromosome; N.I.: not identified.
doi:10.1371/journal.pone.0033563.t001
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4 cells/50 ml/well), nearly
all cells were killed by PA treatment at 0.8 nM or higher during a
7-day cultivation period (Figure 2B). Based on these results, we
chose 1.2 nM PA for the selection of GPI anchor-deficient cells for
the rest of the study.
Characterization of PA
r DT40 cells
In order to confirm whether the DT40 cells that survived PA
exposure were indeed PA
r cells, we re-challenged the cells to
different concentrations of PA. Compared to intact DT40 cells,
six different clones of DT40 cells that survived the first PA
treatment at 1.2 nM were resistant to cell death induced by PA
(Figure 3A), indicating that accurate selection of PA
r DT40 cells
is feasible using 96-well plates. Using one of the PA
r clones, we
seeded different numbers of PA
r c e l l s( 0t o8 0c e l l s / p l a t e )o n t o
96-well plates containing intact DT40 cells (40610
3 cells/well)
to validate the accuracy of the PA selection step of the assay.
We detected a linear relationship between expected and
Figure 2. Cell survival after PA exposure. (A) In a low cell density experiment using a 24-well plate (2.5610
3 cells/250 mL/well), DT40 cells were
exposed to PA (0.0221–0.125 nM). After a three-day cultivation, cell viability was determined by XTT. Each point represents the mean and S.D. (bars)
from three independent experiments. (B) In a high cell density experiment using a 96-well plate (4610
4 cells/50 ml/well), DT40 cells were exposed to
PA (0.5–1.2 nM). After a seven-day incubation, colony formation was scored visually using an inverted microscope. Each point represents the mean
and S.D. (bars) from three independent experiments.
doi:10.1371/journal.pone.0033563.g002
Figure 3. Characterization of PA-resistant (PA
r) DT40 cells and validation of PA selection-based GPI anchor-deficient cell detection
assay. (A) In a low cell density experiment using a 24-well plate (2.5610
3 cells/250 mL/well), the intact DT40 cells and six different clones of DT40
cells that survived from the first PA treatment at 1.2 nM were exposed to PA (0.0221–1.2 nM). After a three-day cultivation, cell viability was
determined by XTT. Each point represents the mean and S.D. (bars) from three independent experiments for DT40 cells and single experiment for six
different clones of DT40 cells resistant to PA. (B) Using one of the PA
r clones used for Figure 3A, different numbers of PA
r cells (0 to 80 cells/plate)
were seeded onto 96-well plates containing intact DT40 cells (40610
3 cells/well) to validate the accuracy of the PA selection step of the assay. The
cells were exposed to PA at 1.2 nM. After a seven-day incubation, colony formation was scored visually using an inverted microscope. Plating
efficiency was also determined using PA
r cells.
doi:10.1371/journal.pone.0033563.g003
PIGO Gene Mutation Assay in DT40 Cell
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33563observed frequencies of PA
r cells (R
2=0.99, y=0.501x+1)
(Figure 3B).
Optimization of detection of GPI anchor-deficient DT40
cells exposed to MMS
MMS is a well-studied mutagen; therefore, we utilized this
reactive agent to optimize the PA-selection-based GPI anchor-
deficient cell detection assay. The effect of 24-hour MMS exposure
at 100 mM on cell growth was first evaluated over three days after
MMS exposure. While the first 24-hour incubation with 100 mM
MMS decreased the growth rate to ,80% compared to the
control, the cell growth rate recovered to control level after
replenishing the medium without MMS (Figure 4A). It has been
well established that, following a mutation at the HPRT locus, time
is required before the new thioguanine-resistant phenotype is
completely expressed [27]. We next optimized the length of the
phenotype expression period in the PA
r DT40 cells after MMS
treatment. The length of expression time showing a maximum
mutant frequency depends on segregation of the mutant allele
from the normal allele by cell proliferation; loss of the original,
normal gene activity due to dilution or degradation of wild-type
protein; and loss of original, wild-type mRNA due to its dilution or
Figure 4. Frequency of GPI anchor-deficient DT40 cells exposed to MMS. (A) The effect of 24-hour MMS exposure at 0, 1, 3, 10, 30, or
100 mM on cell growth of DT40 cells was evaluated over three days after MMS exposure. The cell growth assay was performed during/after MMS
treatment. Each point represents the mean and S.D. (bars) from three independent experiments. (B) The length of the phenotype expression period in
the PA
r DT40 cells was optimized after 100 mM MMS treatment for 24 hours. The frequency of PA
r DT40 cells was determined before and after MMS
treatment. Each point represents the mean and S.D. (bars) from at least three independent experiments. (C) Frequency of PA
r DT40 cells was
determined after exposure to MMS at different concentrations. DT40 cells were exposed to MMS at 0, 1, 3, 10, 30, 40, 60, and 100 mM for 24 hours.
The cells were further cultured for five days in fresh medium without MMS. The frequency of PA
r DT40 cells was determined for each group. Each
point represents the mean and S.D. (bars) from at least three independent experiments. P,0.05. Discontinued line shows the mean and S.D. of
mutational frequency in the control samples (0.560.8 mutants/10
6 cells).
doi:10.1371/journal.pone.0033563.g004
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r cells was detected 3 days
after MMS treatment, and the number of PA
r cells reached nearly
maximum at 5 days after MMS treatment (Figure 4B). This
indicates that a 4- to 5-day cultivation is required for full
phenotypic expression (GPI anchor deficiency) following MMS
treatment. We also detected a decrease in the frequency of PA
r
DT40 cells after a 6-day expression period. This reduction appears
to be due to slower proliferation rates of mutant than non-mutant
cells; therefore, propagation longer than five days may lead to
further decreases in the PA
r cell frequencies. Based on this time-
course experiment, we chose a 24-hour MMS exposure plus a 5-
day phenotype expression period for most of the experiments in
this study. While the PA
r cells were allowed to grow for 5–7 days
in the presence of PA before identifying resistant cells, small
colonies of PA
r cells were usually detectable as early as 3 days after
the PA treatment.
Frequency of GPI anchor-deficient DT40 cells exposed to
MMS at different concentrations
MMS has recently been evaluated for its low dose effects in the
HPRT and TK genes in the AHH-1 human lymphoblastoid cell
line [28]. MMS exposure for 24 hours caused a nonlinear (hockey-
stick-shaped dose-response) curve containing a range of non-
mutagenic low doses in both mutation assays. We next addressed
whether the appearance rate of PA
r cells after MMS treatment
showed a non-linear dose response curve in DT40 cells. DT40
cells were exposed to different concentrations of MMS to
determine an increase in the rate of PA
r cell formation. Cell
growth inhibition was observed at 80 or 100 mM after 24-hour
MMS exposure, but not at 60 mM or lower (Figure 4A and data
not shown). We detected the hockey stick-like dose-response curve
in the incidence of PA
r cells (Figure 4C). These results indicate that
a PA-based selection is a useful tool to detect GPI anchor synthesis
gene mutations in DT40 cells. When we compared different
mutation assays in different cell lines, we recognized that the PIG-
O mutation assay in DT40 cells required slightly higher
concentrations of MMS compared to the HPRT mutation assay
in AHH-1 cells [28]. This difference could be due to the variation
of the functionality of various DNA repair pathways against DNA
lesions caused by MMS.
PIG-O gene is mutated in PA
r DT40 cells
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired
hematopoietic stem-cell disorder resulting from the clonal
expansion of hematopoietic cells with somatic mutations in the
X-linked PIG-A gene in humans. The affected cells with PIG-A
gene mutations are deficient in GPI-anchored proteins. PNH is
frequently associated with hemolytic anemia, a hypercoagulable
state, and bone marrow failure [29]. Many proteins on the
eukaryotic cell surface are anchored by GPI [30]. While the PIG-
A gene is located in the autosome in DT40 cells, there is a single
copy of the PIG-O gene located on the Z chromosome in the cells
derived from the female chicken. The chicken PIG-O gene codes
for a protein that contains 1145 amino acids (XP_001232870).
The percent amino acid sequence identity of the chicken PIG-O
with the human PIG-O (1089 amino acids, NP_116023) is 94%.
To address whether PA
r DT40 cells possess a PIG-O gene
mutation, we next sequenced PIG-O cDNA in both normal
DT40 cells and DT40 cells resistant to PA. Figure S1 shows the
comparison between the PIG-O cDNA sequences found in DT40
cells and those found in chicken (XM_001232869). The cDNA
sequence in parental DT40 cells was used as a reference for
determining DNA alterations in PA
r DT40 cells. Among all the
mutations detected in the sequence levels observed in DT40 cells
exposed to MMS, we identified that ,55% of the mutations are
located at A:T sites, including a high frequency of A to T trans-
version mutations and three frameshift mutations (Table 2). In
contrast, there were no transition mutations out of the 18
mutations. We also observed three clones with deletions ranging
from 20 to 204 bases and three clones with insertions ranging
f r o m2t o6b a s e s .W h e nw ec o m p a r e do u rr e s u l t si nt h e
mutational spectrum of the PIG-O gene in DT40 cells and the
previously published spectrum of the hprt gene in CHO cells,
there was a drastic difference in the mutational spectrum caused
by MMS exposure. We detected no G/CRA/T transition
mutations in our study whereas predominant G/CRA/T
transition mutations at the hprt gene have been frequently
reported in Chinese hamster fibroblast/ovary cells [31,32]. This
can be explained by a O
6-methylguanine-DNA-methyltransfer-
ase deficiency in these Chinese hamster fibroblast/ovary cells,
which leads to the accumulation of mutagenic O
6-methylgua-
nine. In contrast, the high frequency of A/TRT/A trans-version
mutations in the PIG-O gene in DT40 cells is in agreement with
the mutational spectrum of target genes obtained from in vivo
exposure to MMS. For example, mutations with a high
frequency of A/TRT/A trans-versions have been demonstrated
at the hprt gene in splenic T-lymphocytes from N-methylpurine-
DNA glycosylase knockout mice exposed to MMS and the
vermilion locus of Drosophila melanogaster exposed to MMS [33–35].
The A/TRT/A trans-version mutations found in MMS
exposure-derived PA
r DT40 cells appear to be due to N3-
methyladenine or base excision repair intermediates, such as
abasic sites and single strand breaks originated from N3-
methyladenine [36,37]. Although more work needs to be done
to characterize the spectrum of spontaneous mutations (Table 3),
most of the PIG-O gene mutations in DT40 cells exposed to
MMS represent mutations derived from DNA damage caused by
MMS due to the increase of mutation frequency by more than
45 times over the spontaneous mutation rate (Figure 4C).
Furthermore, it is worthwhile to mention that our preliminary
study showed a high background of PIG-O mutations in some of
DNA repair gene-deficient DT40 cells (e.g., XPA-deficient cells),
confirming the important value of this new mutation assay in
DT40 cell system. It has been previously reported that PIG-O
and PIG-F act together in transferring phosphoethanolamine to
the third mannose during GPI anchor synthesis in CHO cells
[26]. In the same study, the Pig-o gene mutant cells showed a
pronounced decrease, but not a complete loss, in the expression
of Thy-1, a GPI-anchored protein, in CHO cells. The Pig-o gene
mutant CHO cells also expressed no detectable CD59 and only
10% of normal levels of decay-accelerating factor (both CD59
and decay-accelerating factor are GPI-anchored proteins) [38],
indicating that Pig-o is involved in and nearly essential for GPI
anchor biosynthesis [26]. We attempted to detect PIG-O mutants
using fluorescent-tagged proaerolysin (FLAER)-coupled FACS
analysis; however, the separation between FLAER-positive and
negative DT40 cells was not accomplished in our study. This
could be due to partial expression of GPI-anchored proteins on
the membrane in PIG-O mutants as described above. Therefore,
we chose the PA selection-based method instead of the FACS-
based analysis to analyze the frequency of GPI-anchor deficient
DT40 cells with high specificity. As described above, PA
selection-based GPI-deficiency cell analysis demonstrated a
reasonable dose-response relationship between MMS concentra-
tions and the frequency of GPI-deficient cells, indicating that this
assay is a useful tool for characterizing mutation events in the
DT40 cell system.
PIGO Gene Mutation Assay in DT40 Cell
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Materials
Penicillin/streptomycin and methyl methanesulfonate (MMS)
were obtained from Sigma (St. Louis, MO). Trizol, Taq DNA
polymerase, RPMI 1640 culture medium and chicken serum were
acquired from Invitrogen (Carlsbad, CA). Fetal bovine serum
(FBS) was obtained from PAA laboratories Inc (Etobicoke,
Canada). iScript cDNA synthesis kit and PCR primers were
acquired from Bio-Rad Laboratories (Hercules, CA) and Thermo
Fisher Scientific (Waltham, MA), respectively. Wizard SV Gel/
PCR Clean-Up System and PA were purchased from Promega
(Madison, WI) and the University of Saskatchewan (Saskatoon,
Canada), respectively.
Cell growth assay after MMS exposure
DT40 cells [6] were cultured in a manner previously reported
[6,7]. We performed two different types of cell survival assays:
Low cell density experiment. One of the cell survival assays
was conducted as described previously for the DNA damage
response analysis [6,7]. Briefly, suspended DT40 cells (,2.5610
3
cells per 250 mL per well) were seeded into 24-well plates, exposed
to either PA or MMS, and allowed to divide for 7 to 8 cycles
(approximately 3 days). After cultivation, cell viability was
determined by the XTT assay [6,7].
High cell density experiment. We performed a cell growth
assay during/after MMS treatment. The assay was performed
under the exposure conditions used for the PA-selection-based
GPI anchor-deficient cell detection assay described below. Briefly,
suspended DT40 cells (1. 25610
6 cells/10 ml) were seeded into
10-cm Petri dishes, exposed to MMS, and allowed to cultivate for
24 hours. The number of viable cells was quantitated by the
trypan blue exclusion assay. The culture medium was replenished
and the cells (1. 25610
6 cells/10 ml) were further incubated for
24 hours. This cycle was repeated for 5 days.
PA-selection-based GPI anchor-deficient cell detection
assay
The overall scheme of this assay is shown in Table 4. The cells
were maintained at a concentration of 0.125 to 1.5610
6/mL.
Since the background PA-resistant (PA
r) cell population was low,
we directly used DT40 cells for the assay without re-populating
with PA-sensitive DT40 cells in this study. Cell suspension at
1.25610
6 cells/10 mL was exposed to MMS at different
concentrations for 24 hours at 39.5uC, 5% CO2. The cells were
then washed to remove the MMS and were resuspended in 10-mL
Table 3. Spontaneous mutational spectrum of PIG-O gene in
DT40 cells.
Mutation (cDNA position) Target sequence (59-39)
Deletion
2171 bases (923–1093) AGG(AGC—AGC)AGT
24 bases (1048–1051) GTG(TCTG)AAG
24 bases (1093–1096) AAG(CAGG)TGG
24 bases (1092–1095) CAA(GCAG)GTG
doi:10.1371/journal.pone.0033563.t003
Table 2. Mutational spectrum of PIG-O gene in DT40 cells exposed to MMS at 100 mM.
Mutation (cDNA position) Target sequence (59-39) Amino acid change (codon)
Transversion
AT to TA (840) CCA(T)GGT His to Gln (280)
AT to TA (2009) GCC(T)GAG Leu to Gln (670)
AT to TA (2011) CTG(A)GAA Arg to stop (671)
AT to TA (2332) GCA(A)AGG Lys to stop (778)
AT to TA (2941) TCC(A)AGA Lys to stop (981)
AT to CG (689) ACC(A)CTG His to Pro (230)
AT to CG (950) ACC(T)GGT Leu to Arg (317)
GC to CG (2771) ACT(G)GAA Trp to Ser (924)
GC to TA (2911) TGT(G)AGA Glu to stop (971)
Frameshift
+A (1915) CTT(*)CTG
2T (241) GAA(T)TTG
2A (941) CCC(A)GGT
Insertion/Deletion
+6 bases (1092) CAA(GCAGTT)GCA
+2 bases (2786) TTG(CG)TGG
+4 bases (2873) CAG(GTAT)TTG
2145 bases (497–641) GAA(GAA—GAA)CAG
220 bases (1746–1765) AGC(TGA—CAT)TCC
2204 bases (2669–2872) CTG(AGC—CAG)TTG
doi:10.1371/journal.pone.0033563.t002
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6 cells/10 mL). The culture medium was
replenished daily to maintain appropriate cell concentrations as
described above. The 96-well plates were then loaded with 4610
4
cells/50 mL/well containing 1.2 nM PA (2 plates per sample).
Nonselection plates were prepared by inoculating 2 target cells and
4610
4 lethally lactic acid-pre-treated (50 mM lactic acid for
30 min at 39uC) DT40 cells as feeder cells in 50 ml medium in
each well to determine the plating efficiency in the absence of PA
treatment (2 plates per sample). All plates were incubated for
approximately 7 days at 37uC, in 5% CO2, and in a humidified
atmosphere. Subsequent colony formation was scored visually
using an inverted microscope to determine the mutation frequency
of each dose, calculated as described by Furth et al. [39].
Reverse transcription-polymerase chain reaction
RNA was prepared using Trizol reagent and was reverse-
transcribed using a mixture of random hexamers and Oligo d(T)
according to standard procedures. Primers for PIG-O PCR were
designed using Primer-BLAST (National Center for Biotechnology
Information) based on a predicted chicken PIG-O cDNA sequence
(XM_001232869.1). cDNA (150 ng/25 mL) was PCR-amplified in
20 mM Tris (pH 8.4), 50 mM KCl, 1 mM MgCl2, 0.1 mM
dNTPs, 0.5 mM primers, and 2.5 U Taq polymerase. The cycling
parameters were 94uC for 30 sec, 60uC for 30 sec, and 72uC for
1 min for 35 cycles. The sequences of primers 1–6 are shown in
Table 5. The PCR products were purified on Wizard SV Gel and
PCR Clean-Up System, and the PIG-O coding sequence was
determined in the Genome Analysis Facility (University of North
Carolina at Chapel Hill). Mutations were identified by a
comparison between the PIG-O cDNA sequence of each mutant
clone and the wild-type sequence obtained from intact parental
DT40 cells (Figure S1).
Statistical analysis
A one-way ANOVA, followed by a Dunnett’s posthoc test, was
used to determine if any of the treatment doses were significantly
different from the zero dose in the 24-hour MMS exposure
experiment.
Supporting Information
Figure S1 Comparison between the PIG-O cDNA se-
quences found in DT40 cells and those found in chicken
(XM_001232869).
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